Surgical Release of Hand Tendons with Wrapping of the Released Tendon Using an Amniotic Membrane
Recruiting
Phase 2
Interventional Study
Tendon Adhesion
Tenolysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 16 (estimated)
- Sponsor
- TBF Genie Tissulaire · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether an amniotic membrane can function as an effective anti-adhesive barrier following surgical release of tendon adhesions. The main question the clinical trial aims to answer is:
\- Can wrapping an amniotic membrane around a surgically released tendon help reduce recurrence of adhesions and promote recovery of hand functionality?
Participants w…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Man or woman aged 18 to 65 years old
* Adhesion of a flexor and/or extensor tendon of the hand.
* Adhesion localized to a single finger.
* Adhesion that has been present for at least 3 months following primary repair, despite high-quality rehabilitation. Primary repair is defi…
Contacts